For each of the six risk variants, the researchers reported a 9 to 16 percent increase in the odds of developing CRC.
“We are identifying more and more of these common genetic variants,” Dr. Peters said, “and we can now start to use these variants to define the genetic risk profile of individuals.” Such information can be used to identify those who can benefit from earlier or more frequent screening, such as colonoscopy or stool blood tests,” said Dr. Peters.
Dr. Peters is a research professor at the University of Washington School of Public Health and a member of the Fred Hutchinson Cancer Research Center, both in Seattle. The research team was co-led by the Fred Hutchinson Cancer Research Center and Keck School of Medicine of USC in Los Angeles.
More articles on gastroenterology:
Modernizing Medicine to acquire gMed: 5 things to know
20 GI/endoscopy company updates for the 1st half of 2015
Is upper GI/endoscopy overused?
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.